Abstract
The vascular endothelium was initially viewed as a “semipermeable” barrier between circulating blood and the interstitium and organ parenchyma. It is now evident that the endothelium plays a much more complex and active physiological and pathophysiological role. For example, endothelial cells regulate vascular tone by the release of vasoactive mediators, such as nitric oxide and endothelin, and orchestrate the response to inflammatory stimuli by the expression of vascular adhesion molecules and increased “leakiness” to circulating cells and proteins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jaffe E. A., Nachman R. L., Becker C. G., and Minick C. R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745–2756.
Gimbrone M. A. (1976) Culture of vascular endothelium. Prog. Hemost. Thromb. 3, 1–28.
Schwartz S. M. (1978) Selection and characterization of bovine aortic endothelial cells. In Vitro 14, 966–980.
Richardson S. E., Rotman T. A., Jay V., Smith C. R., Becker L. E., Petric M., et al. (1992) Experimental verocytotoxemia in rabbits. Infect. Immun. 60, 4154–4167.
Boyd B., Tyrrell G., Maloney M., Gyles C., Brunton J., and Lingwood C. (1993) Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs. J. Exp. Med. 177, 1745–1753.
Uchida H., Kiyokawa N., Horie H., Fujimoto J., and Takeda T. (1999) The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome. Pediatr. Res. 45, 133–137.
te Loo D. M., Monnens L. A., van Der Velden T. J., Vermeer M. A., Preyers F., Demacker P. N., et al. (2000) Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95, 3396–3402.
te Loo D. M., Hinsbergh V. W., Heuvel L. P., and Monnens L. A. (2001) Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J. Am. Soc. Nephrol. 12, 800–806.
Louise C. B. and Obrig T. G. (1994) Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro. Microvasc. Res. 47, 377–387.
van Setten P. A., van Hinsbergh V. W., van der Velden T. J., van de Kar N. C., Vermeer M., Mahan J. D., et al. (1997) Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int. 51, 1245–1256.
Van Setten P. A., van Hinsbergh V. W., Van den Heuvel L. P., van der Velden T. J., van de Kar N. C., et al. (1997) Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. J. Am. Soc. Nephrol. 8, 1877–1888.
Williams J. M., Boyd B., Nutikka A., Lingwood C. A., Barnett Foster D. E., Milford D. V., et al. (1999) A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures. Toxicol. Lett. 105, 47–57.
Jacewicz M. S., Acheson D. W., Binion D. G., West G. A., Lincicome L. L., Fiocchi C., et al. (1999) Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. Infect. Immun. 67, 1439–1444.
Thorpe C. M., Hurley B. P., Lincicome L. L., Jacewicz M. S., Keusch G. T., and Acheson D. W. (1999) Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect. Immun. 67, 5985–5993.
van de Kar N. C., Monnens L. A., Karmali M. A., and van Hinsbergh V. W. (1992) Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80, 2755–2764.
Lingwood C. A. (1999) Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology. Biochim. Biophys. Acta 1455, 375–386.
Louise C. B. and Obrig T. G. (1991) Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 59, 4173–4179.
Obrig T. G., Louise C. B., Lingwood C. A., Boyd B., Barley-Maloney L., and Daniel T. O. (1993) Endothelial heterogeneity in Shiga toxin receptors and responses. J. Biol. Chem. 268, 15,484–15,488.
Pijpers A. H., Setten P. A., Heuvel L. P., Assmann K. J., Dijkman H. B., Pennings A. H., et al. (2001) Verocytotoxin-induced apoptosis of human microvascular endothelial cells. J. Am. Soc. Nephrol. 12, 767–778.
Pober J. S. (1998) Activation and injury of endothelial cells by cytokines. Pathol. Biol. (Paris) 46, 159–163.
Inward C. D., Williams J., Chant I., Crocker J., Milford D. V., Rose P. E., et al. (1995) Verocytotoxin-1 induces apoptosis in vero cells. J. Infect. 30, 213–218.
Mangeney M., Lingwood C. A., Taga S., Caillou B., Tursz T., and Wiels J. (1993) Apoptosis induced in Burkitt’s lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res. 53, 5314–5319.
Arab S., Murakami M., Dirks P., Boyd B., Hubbard S. L., Lingwood C. A., et al. (1998) Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells. J. Neurooncol. 40, 137–150.
Kerr J. F., Wyllie A. H., and Currie A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239–257.
Granville D. J., Carthy C. M., Hunt D. W., and McManus B. M. (1998) Apoptosis: molecular aspects of cell death and disease. Lab. Invest. 78, 893–913.
Mitra D., Kim J., MacLow C., Karsan A., and Laurence J. (1998) Role of caspases 1 and 3 and Bcl-2-related molecules in endothelial cell apoptosis associated with thrombotic microangiopathies. Am. J. Hematol. 59, 279–287.
Bitzan M. (2000) Verotoxin-induced endothelial cell activation and death▽molecular and pathogenetic implications. 4th International Symposium and Workshop on “Shiga toxin (Verocytotoxin)-producing Escherichia coli infections,” Kyoto.
Yoshida T., Fukada M., Koide N., Ikeda H., Sugiyama T., Kato Y., et al. (1999) Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo apoptosis. J. Infect. Dis. 180, 2048–2052.
Maciag T., Cerundolo J., Ilsley S., Kelley P. R., and Forand R. (1979) An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc. Natl. Acad. Sci. USA 76, 5674–5678.
Voyta J. C., Via D. P., Butterfield C. E., and Zetter B. R. (1984) Identification and isolation of endothelial cells based on their increased uptake of acetylatedlow density lipoprotein. J. Cell. Biol. 99, 2034–2040.
Lampugnani M. G., Resnati M., Raiteri M., Pigott R., Pisacane A., Houen G., et al. (1992) A novel endothelial-specific membrane protein is a marker of cellcell contacts. J. Cell Biol. 118, 1511–1522.
Gentry M. K. and Dalrymple J. M. (1980) Quantitative microtiter cytotoxicity assay for Shigella toxin. J. Clin. Microbiol. 12, 361–366.
Bitzan M., Klemt M., Steffens R., and Muller-Wiefel D. E. (1993) Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls. Infection 21, 140–145.
Salacinski P. R., McLean C., Sykes J. E., Clement-Jones V. V., and Lowry P. J. (1981) Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal. Biochem. 117, 136–146.
Scatchard G. (1949) The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51, 660–672.
Lingwood C. A., Law H., Richardson S., Petric M., Brunton J. L., De Grandis S., and Karmali M. (1987) Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262, 8834–8839.
Bitzan M., Richardson S., Huang C., Boyd B., Petric M., and Karmali M. A. (1994) Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro. Infect. Immun. 62, 3337–3347.
Sambrook J., MacCallum P. and Russell D. (2001) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Darzynkiewicz Z. and Traganos F. (1998) Measurement of apoptosis. Adv. Biochem. Eng. Biotechnol. 62, 33–73.
Willingham M. C. (1999) Cytochemical methods for the detection of apoptosis. J. Histochem. Cytochem. 47, 1101–1110.
Bitzan M. M., Wang Y., Lin J., and Marsden P. A. (1998) Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. J. Clin. Invest. 101, 372–382.
Flowers M. A. and Marsden P. A. (1994) Expression of endothelin-1 and nitric oxide is coupled to endothelial phenotype, especially growth state. Exp. Nephrol. 2, 115–126.
Manconi F., Markham R., and Fraser I. S. (2000) Culturing endothelial cells of microvascular origin. Methods Cell Sci. 22, 89–99.
Marelli-Berg F. M., Peek E., Lidington E. A., Stauss H. J., and Lechler R. I. (2000) Isolation of endothelial cells from murine tissue. J. Immunol. Methods 244, 205–215.
Lamszus K., Schmidt N. O., Ergun S., and Westphal M. (1999) Isolation and culture of human neuromicrovascular endothelial cells for the study of angiogenesis in vitro. J. Neurosci. Res. 55, 370–381.
Lou J. N., Mili N., Decrind C., Donati Y., Kossodo S., Spiliopoulos A., et al. (1998) An improved method for isolation of microvascular endothelial cells from normal and inflamed human lung. In Vitro Cell. Dev. Biol. Anim. 34, 529–536.
Richard L., Velasco P., and Detmar M. (1998) A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Exp. Cell, Res. 240, 1–6.
Chung-Welch N., Patton W. F., Shepro D., and Cambria R. P. (1997) Twostage isolation procedure for obtaining homogenous populations of microvascular endothelial and mesothelial cells from human omentum. Microvasc. Res. 54, 121–134.
Isobe I., Yanagisawa K., and Michikawa M. (2001) 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) causes Akt phosphorylation and morphological changes in intracellular organellae in cultured rat astrocytes. J. Neurochem. 77, 274–280.
van de Loosdrecht A. A., Ossenkoppele G. J., Beelen R. H., Broekhoven M. G., Drager A. M., and Langenhuijsen M. M. (1993) Apoptosis in tumor necrosis factor-alpha-dependent, monocyte-mediated leukemic cell death: a functional, morphologic, and flow-cytometric analysis. Exp. Hematol. 21, 1628–1639.
Anonymous (2001) Pharmacology Guide. Glaxo Wellcome.
Peter, M. G. and Lingwood, C. A. (2000) Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin. Biochim. Biophys. Acta 1501, 116–124.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Bitzan, M., Maroeska W. M. te Loo, D. (2003). Interaction of Shiga Toxin with Endothelial Cells. In: Philpott, D., Ebel, F. (eds) E. coli. Methods in Molecular Medicine™, vol 73. Humana Press. https://doi.org/10.1385/1-59259-316-X:243
Download citation
DOI: https://doi.org/10.1385/1-59259-316-X:243
Publisher Name: Humana Press
Print ISBN: 978-0-89603-939-1
Online ISBN: 978-1-59259-316-3
eBook Packages: Springer Protocols